(Q50198550)
Statements
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK) (English)
Pierre Michel
Valerie Boige
Thomas Aparicio
Jean Baptiste Bachet
Laetitia Dahan
Côme Lepage
Sylvain Manfredi
Julien Taieb
Janick Selves
Karine Le Malicot
Frederic Di Fiore